News

A key group of government advisers voted to expand the use of vaccines for a common respiratory illness, providing a boost to ...
The U.S. Centers for Disease Control and Prevention's vaccine experts are expected to vote on expanding access to respiratory syncytial virus shots in the second round of their meeting on Wednesday. G ...
GlaxoSmithKline Pharmaceuticals is a subsidiary of the GSK Group in India. Its objective is to get ahead of disease with the ...
Gov. Josh Shapiro announced in October GSK’s $800 million project that is expected to create at least 200 new jobs and retain ...
GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the ...
The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
Shortly after President Donald Trump won his second presidential election in the U.S. last fall, British drugmaker GSK came to federal prosecutors in New York, bearing intel from employees ...
GSK is studying a group of more than a million older adults in the UK to see if its shingles vaccine lowers the risk of dementia. The British drugs group, led by boss Emma Walmsley, is using the ...
GSK said last year the antibiotic succeeded in a late-stage trial and plans to seek approval in that indication as well. GSK scientists discovered the drug, which was developed in part through the ...
The headquarters building and studio for Channel 9 (WCPO-TV) is for sale, according to officials at Downtown-based The E.W. Scripps Co., which owns the building and the ABC affiliate. WCPO hopes ...
GSK is opening the door to a new era in urinary tract infection (UTI) treatment with its Blujepa, the first in a new class of oral antibiotics for the condition in nearly 30 years. Blujepa, also ...
GSK Plc is studying a large group of elderly adults in the UK to determine if its blockbuster shingles vaccine reduces the risk of dementia, potentially opening the door to an expanded label for ...